Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Obesity gene identified

April 19, 1996

Warner-Lambert reports NPY1 antagonist

April 19, 1996

Warner-Lambert, Pfizer intend to copromote atorvastatin

April 19, 1996

FDA approves new indication for Pravachol

April 19, 1996

ACAT inhibitor reported by Nisshin Flour Milling

April 19, 1996

Human Genome Sciences' research into cathepsin K

April 19, 1996

Fujisawa describes cathepsin L/B inhibitor of fungal origin

April 19, 1996

Cortecs' oral salmon calcitonin shows favorable phase II results

April 19, 1996

Vivus files NDA for Muse

April 12, 1996

Testosterone transdermal patch approved in Sweden

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...